Most major pharmacy chains will fill telehealth prescriptions for controlled substances, but not all of them, and individual pharmacists have significant discretion to refuse. The legal framework allowing controlled substances to be prescribed via telehealth without a prior in-person visit is currently authorized through December 31, 2026, under a temporary DEA extension. Whether your prescription actually gets filled depends on the pharmacy’s corporate policy, the telehealth platform that issued it, and several practical factors you can influence.
Which Major Pharmacies Fill These Prescriptions
CVS, Walgreens, and Walmart all operate pharmacies that can legally fill telehealth-issued controlled substance prescriptions, but each has placed restrictions on specific telehealth companies. In 2022, both CVS and Walmart stopped filling controlled substance prescriptions from the telehealth platforms Cerebral and Done Health after scrutiny of those companies’ prescribing practices. Walgreens also tightened its approach around the same time.
It’s worth noting that Walgreens’ own telehealth service explicitly does not prescribe controlled substances, including stimulants, benzodiazepines, and narcotics. But that restriction applies to its in-house virtual care platform, not to outside prescriptions sent to a Walgreens pharmacy by a separate telehealth provider. A Walgreens pharmacist can still fill a legitimate controlled substance prescription written by an outside telehealth clinician, subject to the pharmacist’s professional judgment.
Independent pharmacies often have more flexibility than chain pharmacies. They typically don’t have corporate-level blocks on specific telehealth platforms and may be more willing to work with you if the prescription meets legal requirements. Smaller pharmacy chains and compounding pharmacies also tend to evaluate prescriptions on a case-by-case basis rather than applying blanket restrictions.
Why Pharmacies Refuse Telehealth Prescriptions
Even when a pharmacy’s corporate policy allows telehealth prescriptions for controlled substances, individual pharmacists have the legal right (and in many states, the obligation) to refuse any prescription they believe isn’t legitimate. Pharmacists look for what the industry calls “red flags,” and telehealth prescriptions trigger several of them by default.
The most common red flags pharmacists watch for include:
- Geographic distance. If your prescriber is far from both you and the pharmacy, pharmacists view this with suspicion. The threshold varies by pharmacist, but a telehealth doctor in another state prescribing to a patient who then fills locally can raise questions.
- New patient status. Walking into a pharmacy for the first time with a controlled substance prescription from a telehealth provider is one of the strongest red flags.
- Paying cash instead of insurance. Bypassing insurance to pay out of pocket for a controlled substance draws scrutiny, since it avoids the verification layer that insurance provides.
- Multiple controlled substances from different prescribers. If your prescription history shows stimulants from one provider and benzodiazepines from another, pharmacists are trained to flag this.
These criteria aren’t published on a sign behind the counter, but they’re well documented in pharmacy practice literature. Understanding them helps explain why the same prescription might be filled at one pharmacy and refused at another.
The DEA Rule That Makes This Possible
Before the pandemic, federal law generally required an in-person medical visit before a clinician could prescribe a controlled substance. COVID-era emergency rules suspended that requirement, and the DEA has extended those flexibilities multiple times. The current extension, issued jointly with the Department of Health and Human Services, runs through December 31, 2026.
This means a telehealth provider can legally prescribe Schedule II through V controlled substances (including ADHD stimulants, certain anxiety medications, and some pain medications) without ever seeing you in person. The prescriber still needs a valid DEA registration and must be licensed in your state. If the DEA allows these flexibilities to expire or replaces them with stricter permanent rules, pharmacies would need to verify that an in-person visit occurred before filling the prescription.
State Laws Add Another Layer
Federal rules set the floor, but your state may impose additional restrictions on telehealth prescribing for controlled substances. Some states require a video visit (not just a phone call or online questionnaire) for controlled substance prescriptions. Others limit which schedules of controlled substances can be prescribed via telehealth, or require an established patient-provider relationship before certain medications can be prescribed remotely.
The prescriber’s state license matters too. Your telehealth clinician must be licensed in the state where you’re located at the time of the visit, not just in the state where they practice. If there’s a mismatch, a pharmacist can and likely will refuse to fill the prescription.
How to Improve Your Chances of Getting It Filled
If you have a legitimate telehealth prescription for a controlled substance, a few practical steps reduce the likelihood of a refusal. Use a pharmacy where you already have a prescription history. Pharmacists are far more comfortable filling a controlled substance for an existing patient than for someone they’ve never seen. If you’ve been filling other medications at a particular pharmacy for months or years, that history works in your favor.
Use your insurance when possible. Cash payments for controlled substances are one of the most cited red flags in pharmacy practice. Even if your copay is higher than the cash price, running the prescription through insurance signals legitimacy.
Choose a telehealth provider with an established reputation. The platforms that faced pharmacy bans in 2022 drew scrutiny because of high-volume prescribing practices that regulators questioned. Telehealth services affiliated with major health systems, or providers you’ve seen in person before who transitioned to telehealth follow-ups, are far less likely to trigger pharmacy-level concerns.
If a pharmacy refuses your prescription, ask why. Pharmacists aren’t always required to give a detailed explanation, but many will tell you enough to understand whether the issue is with the telehealth platform, the prescription itself, or a policy they can’t override. You’re within your rights to transfer the prescription to another pharmacy. Independent pharmacies, in particular, may be worth trying if a chain pharmacy declines.
Schedule II vs. Schedule III Through V
The schedule of the controlled substance matters. Schedule II medications, which include most ADHD stimulants and stronger pain medications, face the heaviest scrutiny. These prescriptions cannot be called in by phone in most states and typically require an electronic prescription sent directly from the provider to the pharmacy. Refills aren’t allowed for Schedule II drugs; you need a new prescription each time.
Schedule III through V medications, which include some sleep aids, certain anti-anxiety medications, and lower-risk controlled substances, face fewer barriers at the pharmacy level. These can often be refilled and are less likely to trigger the same degree of pharmacist skepticism when they originate from a telehealth visit. If your medication falls into one of these lower schedules, you’ll generally have an easier time getting it filled regardless of which pharmacy you use.